TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti–PD-1 tumor immunotherapy
Science Immunology · 17.05.2024 · 9 (95)
DOI: 10.1126/sciimmunol.adi5374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 17.05.2024. Verfasst von Blanda Di Luccia und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Immunotherapy, Macrophages, Membrane Glycoproteins. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
The gut microbiota and tumor-associated macrophages (TAMs) affect tumor responses to anti–programmed cell death protein 1 (PD-1) immune checkpoint blockade. Reprogramming TAM by either blocking or deleting the macrophage receptor triggering receptor on myeloid cells 2 (TREM2) attenuates tumor growth, and lack of functional TREM2 enhances tumor elimination by anti–PD-1. Here, we found that anti–PD-1 treatment combined with TREM2 deficiency in mice induces proinflammatory programs in intestinal macrophages and a concomitant expansion of Ruminococcus gnavus in the gut microbiota. Gavage of wild-type mice with R. gnavus enhanced anti–PD-1–mediated tumor elimination, recapitulating the effect occurring in the absence of TREM2. A proinflammatory intestinal environment coincided with expansion, increased circulation, and migration of TNF-producing CD4 + T cells to the tumor bed. Thus, TREM2 remotely controls anti–PD-1 immune checkpoint blockade through modulation of the intestinal immune environment and microbiota, with R. gnavus emerging as a potential probiotic agent for increasing responsiveness to anti-PD-1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Immunology, Washington University School of Medicine in Saint Louis, St. Louis, MO 63110, USA.
- Department of Microbiology and Immunology, Stanford University, Stanford, CA 94305, USA.
- Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO 63110, USA.
ORCID-Profile: Blanda Di Luccia, Martina Molgora, Darya Khantakova, Natalia Jaeger, Hao-Wei Chang, Rafael S Czepielewski, Beth A Helmink, Emily J Onufer, José L Fachi, Tihana Trsan, Patrick F Rodrigues, JinChao Hou, Jennifer K Bando, Cristiane Sécca da Silva, Marina Cella, Susan Gilfillan, Robert D Schreiber, Jeffrey I Gordon, Marco Colonna
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Di Luccia, B., Molgora, M., Khantakova, D., Jaeger, N., Chang, H. W., Czepielewski, R. S., Helmink, B. A., Onufer, E. J., Fachi, J. L., Bhattarai, B., Trsan, T., Rodrigues, P. F., Hou, J., Bando, J. K., da Silva, C. S., Cella, M., Gilfillan, S., Schreiber, R. D., Gordon, J. I., & Colonna, M. (2024). TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti–PD-1 tumor immunotherapy. Science Immunology, 9(95). https://doi.org/10.1126/sciimmunol.adi5374
Vancouver
Di Luccia B, Molgora M, Khantakova D, Jaeger N, Chang HW, Czepielewski RS, et al. TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti–PD-1 tumor immunotherapy. Science Immunology. 2024;9(95). doi:10.1126/sciimmunol.adi5374
BibTeX
@article{DiLuccia2024,
author = {Di Luccia, Blanda and Molgora, Martina and Khantakova, Darya and Jaeger, Natalia and Chang, Hao-Wei and Czepielewski, Rafael S and Helmink, Beth A and Onufer, Emily J and Fachi, José L and Bhattarai, Bishan and Trsan, Tihana and Rodrigues, Patrick F and Hou, JinChao and Bando, Jennifer K and da Silva, Cristiane Sécca and Cella, Marina and Gilfillan, Susan and Schreiber, Robert D and Gordon, Jeffrey I and Colonna, Marco},
title = {TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti–PD-1 tumor immunotherapy},
journal = {Science Immunology},
year = {2024},
volume = {9},
number = {95},
doi = {10.1126/sciimmunol.adi5374}
}
EUVIMED